Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1435-4373

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland ; volume:41 ; number:6 ; day:28 ; month:4 ; year:2022 ; pages:997-999 ; date:6.2022
European journal of clinical microbiology & infectious diseases ; 41, Heft 6 (28.4.2022), 997-999, 6.2022

Creator: Ahava, Maarit J.
Jarva, Hanna
Jääskeläinen, Anne J.
Lappalainen, Maija
Vapalahti, Olli
Kurkela, Satu

Contributor: SpringerLink (Online service)

DOI: 10.1007/s10096-022-04448-x

URN: urn:nbn:de:101:1-2022072821021523984072

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Ahava, Maarit J.
Jarva, Hanna
Jääskeläinen, Anne J.
Lappalainen, Maija
Vapalahti, Olli
Kurkela, Satu
SpringerLink (Online service)

Other Objects (12)

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations

High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron

The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

SARS‐CoV‐2 Omicron emergence urges for reinforced One‐Health surveillance

Emergence and spread of JN.1 COVID-19 variant

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations

High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron

The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

SARS‐CoV‐2 Omicron emergence urges for reinforced One‐Health surveillance

Emergence and spread of JN.1 COVID-19 variant

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations

High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron

The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

SARS‐CoV‐2 Omicron emergence urges for reinforced One‐Health surveillance

Emergence and spread of JN.1 COVID-19 variant

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations

High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron

The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

SARS‐CoV‐2 Omicron emergence urges for reinforced One‐Health surveillance

Emergence and spread of JN.1 COVID-19 variant

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations

High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron

The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

SARS‐CoV‐2 Omicron emergence urges for reinforced One‐Health surveillance

Emergence and spread of JN.1 COVID-19 variant

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations

High vaccine effectiveness against severe COVID-19 in the elderly in Finland before and after the emergence of Omicron

The Emergence of the Omicron (B.1.1.529) SARS-CoV-2 Variant: What is the Impact on the Continued Pandemic?

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Charge Matters: Mutations in Omicron Variant Favor Binding to Cells

Clinical characteristics and booster vaccine effectiveness of the Omicron variant

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

Identifying susceptibility of children and adolescents to the Omicron variant (B.1.1.529)

SARS‐CoV‐2 Omicron emergence urges for reinforced One‐Health surveillance

Emergence and spread of JN.1 COVID-19 variant

Effects of the Omicron variant on perinatal outcomes in full-term neonates

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

Related objects

Reset password